Journal of Intensive and Critical Care Nursing

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Opinion Article - Journal of Intensive and Critical Care Nursing (2024) Volume 7, Issue 2

Understanding Hepatic Encephalopathy: Causes, Symptoms, and Management Strategies

Rhyquelle Nascimento*

Department of Psychiatry, Faculty of Medicine, University of Montreal, Montreal, Canada

*Corresponding Author:
Rhyquelle Nascimento
Department of Psychiatry
Faculty of Medicine
University of Montreal, Montreal, Canada
E-mail: nascimentor@med.co.in

Received: 01-Apr-2024, Manuscript No. AAICCN-24-134940; Editor assigned: 03-Apr-2024, PreQC No. AAICCN-24-134940(PQ); Reviewed: 17-Apr-2024, QC No. AAICCN-24-134940; Revised: 19-Apr-2024, Manuscript No. AAICCN-24-134940 (R); Published: 26- Apr-2024, DOI:10.35841/aaiccn-7.2.202.

Citation: Rhyquelle N. Understanding Hepatic Encephalopathy: Causes, Symptoms, and Management Strategies. J Intensive Crit Care Nurs. 2024; 7(2):202

Visit for more related articles at Journal of Intensive and Critical Care Nursing

Introduction

Hepatic encephalopathy (HE) is a complex and potentially life-threatening condition that occurs when the liver is unable to adequately remove toxins from the blood, leading to neurological dysfunction. This condition primarily affects individuals with advanced liver disease or acute liver failure. Understanding the causes, symptoms, and management strategies of hepatic encephalopathy is crucial for healthcare professionals to provide timely and effective care for affected patients [1, 2].

Hepatic encephalopathy develops as a result of impaired liver function, which leads to the accumulation of toxic substances in the bloodstream that would normally be metabolized and eliminated by the liver. Chronic liver diseases such as cirrhosis, caused by long-term alcohol abuse, viral hepatitis (such as hepatitis B or C), non-alcoholic fatty liver disease (NAFLD), or other liver conditions, can lead to hepatic encephalopathy. In liver cirrhosis, blood flow may bypass the liver through abnormal connections called portosystemic shunts, allowing toxins to reach the brain without being adequately processed by the liver. Bleeding from the gastrointestinal tract, commonly associated with liver cirrhosis, can lead to an increase in ammonia levels in the blood, contributing to the development of hepatic encephalopathy. Fluid and electrolyte imbalances, often seen in advanced liver disease, can exacerbate hepatic encephalopathy by affecting cerebral function [3, 4].

Symptoms of Hepatic Encephalopathy

The symptoms of hepatic encephalopathy can vary widely in severity and may develop gradually or suddenly. Mild confusion or difficulty concentrating may progress to severe confusion, disorientation, and altered consciousness. Patients may exhibit personality changes, mood swings, irritability, or depression. Difficulty with tasks requiring attention and concentration, such as reading or following instructions, may occur. Tremors, muscle stiffness, and difficulty with coordination and movement may be observed. Patients may experience disturbances in sleep patterns, such as insomnia or daytime sleepiness. Flapping tremor of the hands, known as asterixis, may be present, particularly in more advanced stages of hepatic encephalopathy. Slurred speech or difficulty articulating words may occur [5, 6].

Management Strategies for Hepatic Encephalopathy

The management of hepatic encephalopathy aims to reduce ammonia levels in the blood, correct underlying liver dysfunction, and alleviate symptoms. Lactulose and rifaximin are commonly used to reduce ammonia levels in the gut by promoting the excretion of ammonia in the feces. Lactulose works by acidifying the colon, which traps ammonia as ammonium ions and facilitates its elimination [7, 8].

A low-protein diet may be recommended to reduce the production of ammonia in the gastrointestinal tract. However, protein restriction should be balanced to prevent malnutrition. Identifying and treating precipitating factors such as infections, gastrointestinal bleeding, electrolyte imbalances, and medications that can exacerbate hepatic encephalopathy is essential. Continuous monitoring of neurological status, liver function tests, electrolyte levels, and ammonia levels is necessary to assess the response to treatment and detect complications. Supportive care measures, including hydration, nutritional support, and prevention of aspiration, should be provided as needed. In cases of severe hepatic encephalopathy refractory to medical therapy or in the setting of acute liver failure, liver transplantation may be considered as a definitive treatment option [9, 10].

Conclusion

Hepatic encephalopathy is a serious complication of liver dysfunction that requires prompt recognition and intervention. By understanding the underlying causes, recognizing the signs and symptoms, and implementing appropriate management strategies, healthcare professionals can improve outcomes and quality of life for patients with hepatic encephalopathy. Close collaboration among healthcare providers, including hepatologists, gastroenterologists, critical care specialists, and nurses, is essential to optimize patient care and outcomes in this complex condition.

References

  1. Song BH, Yun SI, Woolley M, Lee YM (2017) Zika Virus: History, Epidemiology, Transmission, and Clinical Presentation.J Neuroimmunol 308: 50-64.

    2. Indexed at, Google Scholar, Cross Ref

  2. Gulland A (2016) Zika Virus Is a Global Public Health Emergency, Declares WHO.BMJ352: 657.

    3. Indexed at, Google Scholar, Cross Ref

  3. Merfeld E, Ben-Avi L, Kennon M, Cerveny KL (2017) Potential Mechanisms of Zika-Linked Microcephaly.Wiley Interdiscip Rev Dev Biol 6: 273.

    4. Indexed at, Cross Ref

  4. Silva VI, Alvarenga C, Abreu C, Tozetto-Mendoza TR Do, Canto CLM, et al. (2018) Potential Effect of Zika Virus Infection on Human Male Fertility?Rev Inst Med Trop Sao Paulo60: 2-5.

    5. Indexed at, Google Scholar, Cross Ref

  5. Elfiky AA (2020) Novel Guanosine Derivatives against Zika Virus Polymerase in Silico.J Med Virol92: 11-16.

    6. Indexed at, Google Scholar, Cross Ref

  6. Myhrvold C, Freije CA, Gootenberg JS, Abudayyeh OO, Metsky HC, et al. (2018) Field-Deployable Viral Diagnostics Using CRISPR-Cas13.Science360: 444-448.

    7. Indexed at, Google Scholar, Cross Ref

  7. Gourinat AC, O’Connor O, Calvez E, Goarant C, Dupont-Rouzeyrol M (2015) Detection of Zika Virus in Urine.Emerg Infect Dis 21: 84-86.

    8. Indexed at, Google Scholar, Cross Ref

  8. Rastogi M, Sharma N, Singh SK (2016) Flavivirus NS1: A Multifaceted Enigmatic Viral Protein.Virol J13: 131.

    9. Indexed at, Google Scholar, Cross Ref

  9. Mendonça PD, Santos LKB, Foguel MV, Rodrigues MAB, Cordeiro MT, et al. (2021) NS1 Glycoprotein Detection in Serum and Urine as an Electrochemical Screening Immunosensor for Dengue and Zika Virus.Anal Bioanal Chem 413: 4873-4885.

    10. Indexed at, Google Scholar, Cross Ref

  10. Peters R, Stevenson M (2019) Zika Virus Diagnosis: Challenges and Solutions.Clin Microbiol Infect25: 142-146.

    11. Indexed at, Google Scholar, Cross Ref

Get the App